Sildenafil
Product Images NDC 68071-2608

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2608 3)

Sildenafil 20mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates a package size of 30 tablets containing Sildenafil Citrate equivalent to 20mg Sildenafil each. It features details such as product number P2215030, directions for use, lot numbers, expiration date placeholders, and storage instructions to keep at controlled temperature 68-77°F. The label also includes warning to keep out of reach of children and contact information for reporting side effects to the FDA.*

FDA Label Image

Figure1 (Sildenafil Figure 1)

A line chart showing estimated cumulative mortality rate (%) over time (years) for three dosage groups: high dose, medium dose, and low dose. The chart includes three stepped lines representing each dose, with the high dose showing the highest mortality rate increase over five years, followed by medium dose and low dose. A table above the chart lists the number of patients at risk for each group at yearly intervals from 0 to 5 years.*

FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

A chart showing fold change and 90% confidence intervals for the effects of various interacting drugs on Sildenafil's pharmacokinetic parameters, including AUC and Cmax. Drugs listed include Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Ritonavir, and Saquinavir, along with dosage adjustment recommendations.*

FDA Label Image

Figure3 (Sildenafil Figure 3)

A forest plot chart illustrating the fold change and 90% confidence intervals (CI) of pharmacokinetic parameters (INR, AUC, Cmax, BT) for various interacting drugs with Sildenafil. The chart includes drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide, with recommendations mainly indicating no dose adjustment except for Ritonavir where coadministration is not recommended.*

FDA Label Image

Figure4 (Sildenafil Figure 4)

A scatter plot with error bars showing change from baseline (meters) against week of study (Weeks 4, 8, 12). Data points represent three groups: placebo, Sildenafil 20mg TID, and Sildenafil 80mg TID. The graph depicts the progression of measurements over time in a clinical study.*

FDA Label Image

Figure5 (Sildenafil Figure 5)

A forest plot showing placebo-corrected change in 6-minute walk distance (meters) for Sildenafil 20 mg TID across various subgroups, including baseline walk distance, etiology of PAH, PH criteria for functional capacity, gender, age, mean PAP, and PVRI. The plot compares group sizes and depicts effect size with confidence intervals for each category.*

FDA Label Image

Figure6 (Sildenafil Figure 6)

A Kaplan-Meier survival curve comparing the percentage of subjects without a clinically worsening event over time between two groups: Placebo and Sildenafil. The x-axis represents days from randomization, and the y-axis shows the percentage without the event, with Sildenafil showing a higher percentage over the course of 112 days.*

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

A line plot showing mean change from baseline in meters over weeks 4, 8, and 12 of study for Sildenafil at dosages 1mg TID, 5mg TID, and 20mg TID. Error bars represent standard error for each treatment group at each time point.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure diagram showing the molecular formula of Sildenafil, the active ingredient in the product by NuCare Pharmaceuticals, Inc. The diagram includes labeled rings and side chains typical of the Sildenafil molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.